Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Acute Kidney Injury IV: Diagnostic Studies and Prevention
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 23, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
1The Department of Nephrology, 452nd Hospital of the Chinese People's Liberation Army, Chengdu, China.
Patients with chronic renal insufficiency anemia have higher hepcidin levels. Increased hepcidin correlates with anemia severity, impacting iron metabolism in renal anemia.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: